Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal Fabio MarsicoMilena CecerePasquale Perrone Filardi ReviewPaper 10 September 2016 Pages: 139 - 148
Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants Molly HowardAndrew LipshutzBetsy Bryant Shilliday OriginalPaper 18 October 2016 Pages: 149 - 156
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study Özcan BaşaranVolkan Doganand Collaborators OriginalPaper 15 November 2016 Pages: 157 - 165
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study Simon ManthaEva LaubeGerald A. Soff OriginalPaper Open access 30 September 2016 Pages: 166 - 171
Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study Jason SuhAmishi DesaiAlexander Hindenburg OriginalPaper 17 October 2016 Pages: 172 - 178
Classification of high-risk with cardiac troponin and shock index in normotensive patients with pulmonary embolism Savas OzsuMuge ErbayTevfik Ozlu OriginalPaper 31 October 2016 Pages: 179 - 183
Encapsulation of eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity Hassan BardaniaSeyed Abbas ShojaosadatiMehrdad Faizi OriginalPaper 24 October 2016 Pages: 184 - 193
Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients Nathan H. WaldronTorijaun DallasIan J. Welsby OriginalPaper 31 October 2016 Pages: 194 - 202
Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”? Vance G. NielsenCharles M. Bazzell OriginalPaper 27 October 2016 Pages: 203 - 208
Novel sila-amide derivatives of N-acetylcysteine protects platelets from oxidative stress-induced apoptosis Manoj PaulRam M. ThusharaKesturu S. Girish OriginalPaper 01 November 2016 Pages: 209 - 216
Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India Amit SharmaKanwaljeet SinghRenu Saxena OriginalPaper 06 January 2017 Pages: 217 - 223
Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia Damien GheldofHélène HaguetFrançois Mullier OriginalPaper 10 January 2017 Pages: 224 - 232
Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis Cristhiam M. Rojas-HernandezThein Hlaing OoHerney Andrés García-Perdomo OriginalPaper 04 October 2016 Pages: 233 - 240
Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics Chrisanna DobrowolskiEdward G. ClarkManish M. Sood ReviewPaper 13 October 2016 Pages: 241 - 247
Continuation of direct oral anticoagulants in the acute phase of ischemic stroke. A case series Manuel CappellariPaolo Bovi Letter to the Editor 03 October 2016 Pages: 248 - 251
A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand Surachai KotirumBunchai ChongmelaxmeNathorn Chaiyakunapruk OriginalPaper 04 October 2016 Pages: 252 - 262
A novel mutation in exon 2 of FGB caused by c.221G>T † substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu † ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and arterial thrombosis Abdul A. ShlebakAlexia D. KatsarouFiona Fernando OriginalPaper Open access 03 November 2016 Pages: 263 - 270
Estimation of right ventricular dysfunction by computed tomography pulmonary angiography: a valuable adjunct for evaluating the severity of acute pulmonary embolism Dong JiaXiao-ming ZhouGang Hou OriginalPaper 12 October 2016 Pages: 271 - 278
Systemic thrombolysis in acute pulmonary embolism: also a matter of “time” Marco ZuinLoris Roncon Letter to the Editor 01 November 2016 Pages: 279 - 282
Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant Zachary D. HaleXiowen KongGeoffrey D. Barnes OriginalPaper 11 November 2016 Pages: 283 - 288